 | • レポートコード：QFJ1-5457 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、124ページ • 納品方法：Eメール（納期：3日） • 産業分類：新技術 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、生殖器ヘルペス研究開発パイプラインの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アシクロビル、アスピダセプト、G-103、GEN-003、GV-2207、ヘルペス-I、HSV-529、プリテリビル、SB-105A10）、用途別市場規模（病院、診療所）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・生殖器ヘルペス研究開発パイプラインの市場動向 ・企業の競争状況、市場シェア ・生殖器ヘルペス研究開発パイプラインの種類別市場規模と予測2016-2027（アシクロビル、アスピダセプト、G-103、GEN-003、GV-2207、ヘルペス-I、HSV-529、プリテリビル、SB-105A10） ・生殖器ヘルペス研究開発パイプラインの用途別市場規模と予測2016-2027（病院、診療所） ・生殖器ヘルペス研究開発パイプラインの北米市場規模2016-2027（アメリカ、カナダ） ・生殖器ヘルペス研究開発パイプラインの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・生殖器ヘルペス研究開発パイプラインのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・生殖器ヘルペス研究開発パイプラインの中南米市場規模2016-2027（メキシコ、ブラジル） ・生殖器ヘルペス研究開発パイプラインの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AiCuris GmbH & Co. KG、AlphaVax, Inc.、Foamix Pharmaceuticals Ltd.、Genocea Biosciences, Inc.、GenVec, Inc.、Immune Design Corp.、Immunovaccine, Inc.、Mymetics Corporation、NanoBio Corporation、NanoViricides, Inc.、PaxVax、Profectus BioSciences, Inc.、Sanofi Pasteur SA、Spider Biotech、Starpharma Holdings Limited、Vaccibody AS、Vaxart, Inc.、Vical Incorporated.） ・結論 |
In 2021, the global Genital Herpes Research and Development Pipeline market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
This report focuses on the global Genital Herpes Research and Development Pipeline status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the Genital Herpes Research and Development Pipeline development in North America, Europe, Japan, China, Southeast Asia, India, etc.
Global Genital Herpes Research and Development Pipeline Scope and Market Size
Genital Herpes Research and Development Pipeline market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Genital Herpes Research and Development Pipeline market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Acyclovir
Aspidasept
G-103
GEN-003
GV-2207
HerpeCide-I
HSV-529
Pritelivir
SB-105A10
Segment by Application
Hospital
Clinic
By Region
North America
Europe
Japan
China
Southeast Asia
India
By Company
AiCuris GmbH & Co. KG
AlphaVax, Inc.
Foamix Pharmaceuticals Ltd.
Genocea Biosciences, Inc.
GenVec, Inc.
Immune Design Corp.
Immunovaccine, Inc.
Mymetics Corporation
NanoBio Corporation
NanoViricides, Inc.
PaxVax
Profectus BioSciences, Inc.
Sanofi Pasteur SA
Spider Biotech
Starpharma Holdings Limited
Vaccibody AS
Vaxart, Inc.
Vical Incorporated.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genital Herpes Research and Development Pipeline Market Size Growth Rate by Type (2021-2027)
1.2.2 Acyclovir
1.2.3 Aspidasept
1.2.4 G-103
1.2.5 GEN-003
1.2.6 GV-2207
1.2.7 HerpeCide-I
1.2.8 HSV-529
1.2.9 Pritelivir
1.2.10 SB-105A10
1.3 Market by Application
1.3.1 Global Genital Herpes Research and Development Pipeline Market Share by Application (2021-2027)
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Genital Herpes Research and Development Pipeline Market Size
2.2 Genital Herpes Research and Development Pipeline Market Size by Regions
2.2.1 Genital Herpes Research and Development Pipeline Growth Rate by Regions (2021-2027)
2.2.2 Genital Herpes Research and Development Pipeline Market Share by Regions (2021-2027)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 Genital Herpes Research and Development Pipeline Revenue by Players (2020-2021)
3.2 Genital Herpes Research and Development Pipeline Key Players Headquaters and Area Served
3.3 Key Players Genital Herpes Research and Development Pipeline Product/Solution/Service
3.4 Date of Enter into Genital Herpes Research and Development Pipeline Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and by Application
4.1 Global Genital Herpes Research and Development Pipeline Market Size by Type (2021-2027)
4.2 Global Genital Herpes Research and Development Pipeline Market Size by Application (2021-2027)
5 North America
5.1 North America Genital Herpes Research and Development Pipeline Market Forecast (2021-2027)
5.2 Genital Herpes Research and Development Pipeline Key Players in North America
5.3 North America Genital Herpes Research and Development Pipeline Market Size by Type
5.4 North America Genital Herpes Research and Development Pipeline Market Size by Application
6.4.4 Canada
6 Europe
6.1 Europe Genital Herpes Research and Development Pipeline Market Forecast (2021-2027)
6.2 Genital Herpes Research and Development Pipeline Key Players in Europe
6.3 Europe Genital Herpes Research and Development Pipeline Market Size by Type
6.4 Europe Genital Herpes Research and Development Pipeline Market Size by Application
7 Japan
7.1 Japan Genital Herpes Research and Development Pipeline Market Forecast (2021-2027)
7.2 Genital Herpes Research and Development Pipeline Key Players in Europe
7.3 Japan Genital Herpes Research and Development Pipeline Market Size by Type
7.4 Japan Genital Herpes Research and Development Pipeline Market Size by Application
8 Rest of World
8.1 China
8.1.1 China Genital Herpes Research and Development Pipeline Market Analysis
8.1.2 Key Players in China
8.2 Southeast Asia
8.2.1 Southeast Asia Genital Herpes Research and Development Pipeline Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India Genital Herpes Research and Development Pipeline Market Analysis
8.3.2 Key Players in India
9 International Player Profiles
9.1 AiCuris GmbH & Co. KG
9.1.1 AiCuris GmbH & Co. KG Company Details
9.1.2 AiCuris GmbH & Co. KG Description and Business Overview
9.1.3 AiCuris GmbH & Co. KG Genital Herpes Research and Development Pipeline Introduction
9.1.4 AiCuris GmbH & Co. KG Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
9.1.5 AiCuris GmbH & Co. KG Recent Development
9.2 AlphaVax, Inc.
9.2.1 AlphaVax, Inc. Company Details
9.2.2 AlphaVax, Inc. Description and Business Overview
9.2.3 AlphaVax, Inc. Genital Herpes Research and Development Pipeline Introduction
9.2.4 AlphaVax, Inc. Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
9.2.5 AlphaVax, Inc. Recent Development
9.3 Foamix Pharmaceuticals Ltd.
9.3.1 Foamix Pharmaceuticals Ltd. Company Details
9.3.2 Foamix Pharmaceuticals Ltd. Description and Business Overview
9.3.3 Foamix Pharmaceuticals Ltd. Genital Herpes Research and Development Pipeline Introduction
9.3.4 Foamix Pharmaceuticals Ltd. Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
9.3.5 Foamix Pharmaceuticals Ltd. Recent Development
9.4 Genocea Biosciences, Inc.
9.4.1 Genocea Biosciences, Inc. Company Details
9.4.2 Genocea Biosciences, Inc. Description and Business Overview
9.4.3 Genocea Biosciences, Inc. Genital Herpes Research and Development Pipeline Introduction
9.4.4 Genocea Biosciences, Inc. Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
9.4.5 Genocea Biosciences, Inc. Recent Development
9.5 GenVec, Inc.
9.5.1 GenVec, Inc. Company Details
9.5.2 GenVec, Inc. Description and Business Overview
9.5.3 GenVec, Inc. Genital Herpes Research and Development Pipeline Introduction
9.5.4 GenVec, Inc. Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
9.5.5 GenVec, Inc. Recent Development
9.6 Immune Design Corp.
9.6.1 Immune Design Corp. Company Details
9.6.2 Immune Design Corp. Description and Business Overview
9.6.3 Immune Design Corp. Genital Herpes Research and Development Pipeline Introduction
9.6.4 Immune Design Corp. Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
9.6.5 Immune Design Corp. Recent Development
9.7 Immunovaccine, Inc.
9.7.1 Immunovaccine, Inc. Company Details
9.7.2 Immunovaccine, Inc. Description and Business Overview
9.7.3 Immunovaccine, Inc. Genital Herpes Research and Development Pipeline Introduction
9.7.4 Immunovaccine, Inc. Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
9.7.5 Immunovaccine, Inc. Recent Development
9.8 Mymetics Corporation
9.8.1 Mymetics Corporation Company Details
9.8.2 Mymetics Corporation Description and Business Overview
9.8.3 Mymetics Corporation Genital Herpes Research and Development Pipeline Introduction
9.8.4 Mymetics Corporation Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
9.8.5 Mymetics Corporation Recent Development
9.9 NanoBio Corporation
9.9.1 NanoBio Corporation Company Details
9.9.2 NanoBio Corporation Description and Business Overview
9.9.3 NanoBio Corporation Genital Herpes Research and Development Pipeline Introduction
9.9.4 NanoBio Corporation Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
9.9.5 NanoBio Corporation Recent Development
9.10 NanoViricides, Inc.
9.10.1 NanoViricides, Inc. Company Details
9.10.2 NanoViricides, Inc. Description and Business Overview
9.10.3 NanoViricides, Inc. Genital Herpes Research and Development Pipeline Introduction
9.10.4 NanoViricides, Inc. Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
9.10.5 NanoViricides, Inc. Recent Development
9.11 PaxVax
9.11.1 PaxVax Company Details
9.11.2 PaxVax Description and Business Overview
9.11.3 PaxVax Genital Herpes Research and Development Pipeline Introduction
9.11.4 PaxVax Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
9.11.5 PaxVax Recent Development
9.12 Profectus BioSciences, Inc.
9.12.1 Profectus BioSciences, Inc. Company Details
9.12.2 Profectus BioSciences, Inc. Description and Business Overview
9.12.3 Profectus BioSciences, Inc. Genital Herpes Research and Development Pipeline Introduction
9.12.4 Profectus BioSciences, Inc. Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
9.12.5 Profectus BioSciences, Inc. Recent Development
9.13 Sanofi Pasteur SA
9.13.1 Sanofi Pasteur SA Company Details
9.13.2 Sanofi Pasteur SA Description and Business Overview
9.13.3 Sanofi Pasteur SA Genital Herpes Research and Development Pipeline Introduction
9.13.4 Sanofi Pasteur SA Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
9.13.5 Sanofi Pasteur SA Recent Development
9.14 Spider Biotech
9.14.1 Spider Biotech Company Details
9.14.2 Spider Biotech Description and Business Overview
9.14.3 Spider Biotech Genital Herpes Research and Development Pipeline Introduction
9.14.4 Spider Biotech Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
9.14.5 Spider Biotech Recent Development
9.15 Starpharma Holdings Limited
9.15.1 Starpharma Holdings Limited Company Details
9.15.2 Starpharma Holdings Limited Description and Business Overview
9.15.3 Starpharma Holdings Limited Genital Herpes Research and Development Pipeline Introduction
9.15.4 Starpharma Holdings Limited Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
9.15.5 Starpharma Holdings Limited Recent Development
9.16 Vaccibody AS
9.16.1 Company Details
9.16.2 Vaccibody AS Description and Business Overview
9.16.3 Vaccibody AS Genital Herpes Research and Development Pipeline Introduction
9.16.4 Vaccibody AS Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
9.16.5 Vaccibody AS Recent Development
9.17 Vaxart, Inc.
9.17.1 Vaxart, Inc. Company Details
9.17.2 Vaxart, Inc. Description and Business Overview
9.17.3 Vaxart, Inc. Genital Herpes Research and Development Pipeline Introduction
9.17.4 Vaxart, Inc. Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
9.17.5 Vaxart, Inc. Recent Development
9.18 Vical Incorporated.
9.18.1 Vical Incorporated. Company Details
9.18.2 Vical Incorporated. Description and Business Overview
9.18.3 Vical Incorporated. Genital Herpes Research and Development Pipeline Introduction
9.18.4 Vical Incorporated. Revenue in Genital Herpes Research and Development Pipeline Business (2020-2021)
9.18.5 Vical Incorporated. Recent Development
10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
Table 1. Global Genital Herpes Research and Development Pipeline Market Size Growth Rate by Type (2021-2027) (US$ Million)
Table 2. Key Players of Acyclovir
Table 3. Key Players of Aspidasept
Table 4. Key Players of G-103
Table 5. Key Players of GEN-003
Table 6. Key Players of GV-2207
Table 7. Key Players of HerpeCide-I
Table 8. Key Players of HSV-529
Table 9. Key Players of Pritelivir
Table 10. Key Players of SB-105A10
Table 11. Global Genital Herpes Research and Development Pipeline Market Size Growth by Application (2021-2027) (US$ Million)
Table 12. Global Genital Herpes Research and Development Pipeline Market Size by Regions (2021-2027) (US$ Million)
Table 13. Global Genital Herpes Research and Development Pipeline Market Share by Regions (2021-2027)
Table 14. Market Top Trends
Table 15. Market Use Cases
Table 16. Global Genital Herpes Research and Development Pipeline Revenue by Players (2020-2021) (US$ Million)
Table 17. Global Genital Herpes Research and Development Pipeline Market Share by Players (2020-2021)
Table 18. Key Players Headquarters and Area Served
Table 19. Key Players Genital Herpes Research and Development Pipeline Product Solution and Service
Table 20. Date of Enter into Genital Herpes Research and Development Pipeline Market
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Genital Herpes Research and Development Pipeline Market Size by Type (2021-2027) (US$ Million)
Table 23. Global Genital Herpes Research and Development Pipeline Market Size Share by Type (2021-2027)
Table 24. Global Genital Herpes Research and Development Pipeline Market Size by Application (2021-2027) (US$ Million)
Table 25. Global Genital Herpes Research and Development Pipeline Market Size Share by Application (2021-2027)
Table 26. North America Key Players Genital Herpes Research and Development Pipeline Revenue (2020-2021) (US$ Million)
Table 27. North America Key Players Genital Herpes Research and Development Pipeline Market Share (2020-2021)
Table 28. North America Genital Herpes Research and Development Pipeline Market Size by Type (2021-2027) (US$ Million)
Table 29. North America Genital Herpes Research and Development Pipeline Market Share by Type (2021-2027)
Table 30. North America Genital Herpes Research and Development Pipeline Market Size by Application (2021-2027) (US$ Million)
Table 31. North America Genital Herpes Research and Development Pipeline Market Share by Application (2021-2027)
Table 32. Europe Key Players Genital Herpes Research and Development Pipeline Revenue (2020-2021) (US$ Million)
Table 33. Europe Key Players Genital Herpes Research and Development Pipeline Market Share (2020-2021)
Table 34. Europe Genital Herpes Research and Development Pipeline Market Size by Type (2021-2027) (US$ Million)
Table 35. Europe Genital Herpes Research and Development Pipeline Market Share by Type (2021-2027)
Table 36. Europe Genital Herpes Research and Development Pipeline Market Size by Application (2021-2027) (US$ Million)
Table 37. Europe Genital Herpes Research and Development Pipeline Market Share by Application (2021-2027)
Table 38. Japan Key Players Genital Herpes Research and Development Pipeline Revenue (2020-2021) (US$ Million)
Table 39. Japan Key Players Genital Herpes Research and Development Pipeline Market Share (2020-2021)
Table 40. Japan Genital Herpes Research and Development Pipeline Market Size by Type (2021-2027) (US$ Million)
Table 41. Japan Genital Herpes Research and Development Pipeline Market Share by Type (2021-2027)
Table 42. Japan Genital Herpes Research and Development Pipeline Market Size by Application (2021-2027) (US$ Million)
Table 43. Japan Genital Herpes Research and Development Pipeline Market Share by Application (2021-2027)
Table 44. Key Players in China
Table 45. Key Players in Southeast Asia
Table 46. Key Players in India
Table 47. AiCuris GmbH & Co. KG Company Details
Table 48. AiCuris GmbH & Co. KG Description and Business Overview
Table 49. AiCuris GmbH & Co. KG Genital Herpes Research and Development Pipeline Product
Table 50. AiCuris GmbH & Co. KG Revenue in Genital Herpes Research and Development Pipeline Business 2020 and 2021
Table 51. AiCuris GmbH & Co. KG Recent Development
Table 52. AlphaVax, Inc. Company Details
Table 53. AlphaVax, Inc. Description and Business Overview
Table 54. AlphaVax, Inc. Genital Herpes Research and Development Pipeline Product
Table 55. AlphaVax, Inc. Revenue in Genital Herpes Research and Development Pipeline Business 2020 and 2021
Table 56. AlphaVax, Inc. Recent Development
Table 57. Foamix Pharmaceuticals Ltd. Company Details
Table 58. Foamix Pharmaceuticals Ltd. Description and Business Overview
Table 59. Foamix Pharmaceuticals Ltd. Genital Herpes Research and Development Pipeline Product
Table 60. Foamix Pharmaceuticals Ltd. Revenue in Genital Herpes Research and Development Pipeline Business 2020 and 2021
Table 61. Foamix Pharmaceuticals Ltd. Recent Development
Table 62. Genocea Biosciences, Inc. Company Details
Table 63. Genocea Biosciences, Inc. Description and Business Overview
Table 64. Genocea Biosciences, Inc. Genital Herpes Research and Development Pipeline Product
Table 65. Genocea Biosciences, Inc. Revenue in Genital Herpes Research and Development Pipeline Business 2020 and 2021
Table 66. Genocea Biosciences, Inc. Recent Development
Table 67. GenVec, Inc. Company Details
Table 68. GenVec, Inc. Description and Business Overview
Table 69. GenVec, Inc. Genital Herpes Research and Development Pipeline Product
Table 70. GenVec, Inc. Revenue in Genital Herpes Research and Development Pipeline Business 2020 and 2021
Table 71. GenVec, Inc. Recent Development
Table 72. Immune Design Corp. Company Details
Table 73. Immune Design Corp. Description and Business Overview
Table 74. Immune Design Corp. Genital Herpes Research and Development Pipeline Product
Table 75. Immune Design Corp. Revenue in Genital Herpes Research and Development Pipeline Business 2020 and 2021
Table 76. Immune Design Corp. Recent Development
Table 77. Immunovaccine, Inc. Company Details
Table 78. Immunovaccine, Inc. Description and Business Overview
Table 79. Immunovaccine, Inc. Genital Herpes Research and Development Pipeline Product
Table 80. Immunovaccine, Inc. Revenue in Genital Herpes Research and Development Pipeline Business 2020 and 2021
Table 81. Immunovaccine, Inc. Recent Development
Table 82. Mymetics Corporation Company Details
Table 83. Mymetics Corporation Description and Business Overview
Table 84. Mymetics Corporation Genital Herpes Research and Development Pipeline Product
Table 85. Mymetics Corporation Revenue in Genital Herpes Research and Development Pipeline Business 2020 and 2021
Table 86. Mymetics Corporation Recent Development
Table 87. NanoBio Corporation Company Details
Table 88. NanoBio Corporation Description and Business Overview
Table 89. NanoBio Corporation Genital Herpes Research and Development Pipeline Product
Table 90. NanoBio Corporation Revenue in Genital Herpes Research and Development Pipeline Business 2020 and 2021
Table 91. NanoBio Corporation Recent Development
Table 92. NanoViricides, Inc. Company Details
Table 93. NanoViricides, Inc. Description and Business Overview
Table 94. NanoViricides, Inc. Genital Herpes Research and Development Pipeline Product
Table 95. NanoViricides, Inc. Revenue in Genital Herpes Research and Development Pipeline Business 2020 and 2021
Table 96. NanoViricides, Inc. Recent Development
Table 97. PaxVax Company Details
Table 98. PaxVax Description and Business Overview
Table 99. PaxVax Genital Herpes Research and Development Pipeline Product
Table 100. PaxVax Revenue in Genital Herpes Research and Development Pipeline Business 2020 and 2021
Table 101. PaxVax Recent Development
Table 102. Profectus BioSciences, Inc. Company Details
Table 103. Profectus BioSciences, Inc. Description and Business Overview
Table 104. Profectus BioSciences, Inc. Genital Herpes Research and Development Pipeline Product
Table 105. Profectus BioSciences, Inc. Revenue in Genital Herpes Research and Development Pipeline Business 2020 and 2021
Table 106. Profectus BioSciences, Inc. Recent Development
Table 107. Sanofi Pasteur SA Company Details
Table 108. Sanofi Pasteur SA Description and Business Overview
Table 109. Sanofi Pasteur SA Genital Herpes Research and Development Pipeline Product
Table 110. Sanofi Pasteur SA Revenue in Genital Herpes Research and Development Pipeline Business 2020 and 2021
Table 111. Sanofi Pasteur SA Recent Development
Table 112. Spider Biotech Company Details
Table 113. Spider Biotech Description and Business Overview
Table 114. Spider Biotech Genital Herpes Research and Development Pipeline Product
Table 115. Spider Biotech Revenue in Genital Herpes Research and Development Pipeline Business 2020 and 2021
Table 116. Spider Biotech Recent Development
Table 117. Starpharma Holdings Limited Company Details
Table 118. Starpharma Holdings Limited Description and Business Overview
Table 119. Starpharma Holdings Limited Genital Herpes Research and Development Pipeline Product
Table 120. Starpharma Holdings Limited Revenue in Genital Herpes Research and Development Pipeline Business 2020 and 2021
Table 121. Starpharma Holdings Limited Recent Development
Table 122. Vaccibody AS Company Details
Table 123. Vaccibody AS Description and Business Overview
Table 124. Vaccibody AS Genital Herpes Research and Development Pipeline Product
Table 125. Vaccibody AS Revenue in Genital Herpes Research and Development Pipeline Business 2020 and 2021
Table 126. Vaccibody AS Recent Development
Table 127. Vaxart, Inc. Company Details
Table 128. Vaxart, Inc. Description and Business Overview
Table 129. Vaxart, Inc. Genital Herpes Research and Development Pipeline Product
Table 130. Vaxart, Inc. Revenue in Genital Herpes Research and Development Pipeline Business 2020 and 2021
Table 131. Vaxart, Inc. Recent Development
Table 132. Vical Incorporated. Company Details
Table 133. Vical Incorporated. Description and Business Overview
Table 134. Vical Incorporated. Genital Herpes Research and Development Pipeline Product
Table 135. Vical Incorporated. Revenue in Genital Herpes Research and Development Pipeline Business 2020 and 2021
Table 136. Vical Incorporated. Recent Development
Table 137. Genital Herpes Research and Development Pipeline Market Trends
Table 138. Genital Herpes Research and Development Pipeline Market Drivers
Table 139. Genital Herpes Research and Development Pipeline Market Challenges
Table 140. Genital Herpes Research and Development Pipeline Market Restraints
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genital Herpes Research and Development Pipeline Market Share by Type in 2021 & 2027
Figure 2. Acyclovir Features
Figure 3. Aspidasept Features
Figure 4. G-103 Features
Figure 5. GEN-003 Features
Figure 6. GV-2207 Features
Figure 7. HerpeCide-I Features
Figure 8. HSV-529 Features
Figure 9. Pritelivir Features
Figure 10. SB-105A10 Features
Figure 11. Global Genital Herpes Research and Development Pipeline Market Share by Application in 2021 & 2027
Figure 12. Hospital Case Studies
Figure 13. Clinic Case Studies
Figure 14. Genital Herpes Research and Development Pipeline Report Years Considered
Figure 15. Global Genital Herpes Research and Development Pipeline Market Size and Growth Rate (2020-2027) (US$ Million)
Figure 16. Global Genital Herpes Research and Development Pipeline Market Share by Regions (2020-2027)
Figure 17. Global Genital Herpes Research and Development Pipeline Market Share by Players in 2021
Figure 18. Global Genital Herpes Research and Development Pipeline Market Size Market Share by Type (2021-2027)
Figure 19. Global Genital Herpes Research and Development Pipeline Market Size Market Share by Application (2021-2027)
Figure 20. Global Genital Herpes Research and Development Pipeline Revenue Market Share by Application in 2021
Figure 21. North America Genital Herpes Research and Development Pipeline Market Size 2021-2027 (US$ Million)
Figure 22. Europe Genital Herpes Research and Development Pipeline Market Size 2021-2027 (US$ Million)
Figure 23. Japan Genital Herpes Research and Development Pipeline Market Size 2021-2027 (US$ Million)
Figure 24. Genital Herpes Research and Development Pipeline Market Size in China (2021-2027) (US$ Million)
Figure 25. Genital Herpes Research and Development Pipeline Market Size in Southeast Asia (2021-2027) (US$ Million)
Figure 26. Genital Herpes Research and Development Pipeline Market Size in India (2021-2027) (US$ Million)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
世界の生殖器ヘルペス治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Genital Herpes Treatment Market The global Genital Herpes Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …- 世界の生殖器ヘルペス治療薬市場規模・現状・予測（2021年-2027年） Genital herpes is a sexually transmitted disease (STD). This STD causes herpetic sores, which are painful blisters (fluid-filled bumps) that can break open and ooze fluid. About 16 percentTrusted Source of people between the ages of 14 and 49 have this STD. Market Analysis and Insights: Global Genit…
- 世界の帯状疱疹治療市場規模・現状・予測（2021年-2027年） Herpes Zoster, also known as zoster or shingles, is a viral disease characterized by a painful skin rash with blisters in a localized area. Typically the rash occurs in a single, wide stripe either on the left or right side of the body or face. Two to four days before the rash occurs there may be ti…
- 世界の口唇ヘルペス治療＆予防市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Treatment and Prevention of Herpes Labialis Market The global Treatment and Prevention of Herpes Labialis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in …
- 世界のメニエール病治療薬パイプライン市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Meniere Disease Drug Pipeline Market The global Meniere Disease Drug Pipeline market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integ…